Suppr超能文献

衰竭和 eomesodermin 下调的快速发展限制了过继转移的小鼠自然杀伤细胞的抗肿瘤活性。

Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.

机构信息

Divisions of Blood and Marrow Transplantation, Stanford University, Stanford, CA 94305, USA.

出版信息

Blood. 2012 Jun 14;119(24):5758-68. doi: 10.1182/blood-2012-03-415364. Epub 2012 Apr 27.

Abstract

Natural killer (NK) cells are potent anti-viral and antitumor "first responders" endowed with natural cytotoxicity and cytokine production capabilities. To date, attempts to translate these promising biologic functions through the adoptive transfer of NK cells for the treatment of cancer have been of limited benefit. Here we trace the fate of adoptively transferred murine NK cells and make the surprising observation that NK cells traffic to tumor sites yet fail to control tumor growth or improve survival. This dysfunction is related to a rapid down-regulation of activating receptor expression and loss of important effector functions. Loss of interferon (IFN)γ production occurs early after transfer, whereas loss of cytotoxicity progresses with homeostatic proliferation and tumor exposure. The dysfunctional phenotype is accompanied by down-regulation of the transcription factors Eomesodermin and T-bet, and can be partially reversed by the forced overexpression of Eomesodermin. These results provide the first demonstration of NK-cell exhaustion and suggest that the NK-cell first-response capability is intrinsically limited. Further, novel approaches may be required to circumvent the described dysfunctional phenotype.

摘要

自然杀伤 (NK) 细胞是具有天然细胞毒性和细胞因子产生能力的强效抗病毒和抗肿瘤“一线反应者”。迄今为止,通过过继转移 NK 细胞来治疗癌症,这些有前途的生物学功能的尝试仅带来了有限的益处。在这里,我们追踪了过继转移的小鼠 NK 细胞的命运,并做出了令人惊讶的观察,即 NK 细胞会转移到肿瘤部位,但不能控制肿瘤生长或提高存活率。这种功能障碍与激活受体表达的快速下调和重要效应功能的丧失有关。转移后早期就会发生干扰素 (IFN)γ产生的丧失,而细胞毒性的丧失则随着体内平衡增殖和肿瘤暴露而进展。功能失调的表型伴随着 Eomesodermin 和 T-bet 转录因子的下调,并且可以通过强制过表达 Eomesodermin 部分逆转。这些结果首次证明了 NK 细胞衰竭,并表明 NK 细胞的一线反应能力本质上是有限的。此外,可能需要新的方法来规避所描述的功能失调表型。

相似文献

引用本文的文献

9
Cancer immunotherapies: A hope for the uncurable?癌症免疫疗法:治愈绝症的希望?
Front Mol Med. 2023 Feb 17;3:1140977. doi: 10.3389/fmmed.2023.1140977. eCollection 2023.
10
Human NK cells and cancer.人自然杀伤细胞与癌症。
Oncoimmunology. 2024 Jul 16;13(1):2378520. doi: 10.1080/2162402X.2024.2378520. eCollection 2024.

本文引用的文献

6
T cell exhaustion.T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验